Axil Capital
Venture Capital
Active
Tokyo, Japan
19
7M
11
2.71
1
0.32
2
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Tokyo. The company was established in Asia in Japan.
The overall number of key employees were 1.
Among the most popular portfolio startups of the fund, we may highlight Frequency Therapeutics. We can highlight the next thriving fund investment areas, such as Genetics, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Axil Capital, startups are often financed by gumi, U.S. Department of Defense, Taiwania Capital. The meaningful sponsors for the fund in investment in the same round are Taiwania Capital, RTW Investments LLC, Polaris Founders Capital. In the next rounds fund is usually obtained by Japan Science and Technology Agency.
The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 2.71
- Follow on index
- 0.32
- Investments by industry
- Health Care (13)
- Biotechnology (7)
- Medical (5)
- Medical Device (4)
- Computer (3) Show 9 more
- Investments by region
-
- Japan (13)
- United States (2)
- Israel (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.89
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Frequency Therapeutics | 23 Jul 2019 | Biotechnology, Genetics, Medical | Late Stage Venture | 62M | United States, Massachusetts, Woburn |
| JOLLY GOOD | 20 Jan 2021 | Internet, Software, Computer | Late Stage Venture | 10M | Chiyoda, Japan |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.